Previous studies showed that neither CDKN2A gene nor CDKN2A (p16) protein expression was an independent predictor, but the combination of gene and protein status was an important predictor of urothelial bladder carcinoma [22]. This evidence concerns the gene CDKN2A and bladder transitional cell carcinoma.